Cosmetic cross-reference

Cupric Oxide

CAS 1317-38-0

Cupric Oxide (CAS 1317-38-0) is a pharmaceutical compound with 0 bioactivity targets and 263 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

263

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Cupric Oxide

CAS Number

1317-38-0

UNII

V1XJQ704R4

InChIKey

QPLDLSVMHZLSFG-UHFFFAOYSA-N

DrugCentral Struct ID

4291

Source Match

DrugCentral (CAS), FDA GSRS (UNII)

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE DrugCentral 5 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Macular degeneration	244	1313.997	10025409
Drug ineffective	249	373.725	10013709
Chronic sinusitis	65	297.365	10009137
Paraesthesia oral	65	271.98	10057372
Procedural pain	64	260.476	10064882

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
CUPRIC OXIDE	21837	SU	MTHSPL
cupric oxide	21837	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Cupric Oxide used for in pharmaceutical contexts?

Cupric Oxide (CAS 1317-38-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Cupric Oxide?

Cupric Oxide has 263 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Macular degeneration, Drug ineffective, Chronic sinusitis, Paraesthesia oral, Procedural pain. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Cupric Oxide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Cupric Oxide with EU status "prohibited".

What clinical phase is Cupric Oxide in?

No phase 1-4 clinical development badge is rendered for Cupric Oxide because the matched compound identifier rows do not contain a max-phase value.